YK, V., C, L., D, N., S, D., K, R., KJ, C., . . . JH, P. (2026). CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia. Blood advances, 10(1), 276. https://doi.org/10.1182/bloodadvances.2025017526
Chicago Style (17th ed.) CitationYK, Valtis, et al. "CAR HEMATOTOX Independently Predicts Outcomes After CD19 CAR-T Therapy for Acute Lymphoblastic Leukemia." Blood Advances 10, no. 1 (2026): 276. https://doi.org/10.1182/bloodadvances.2025017526.
MLA (9th ed.) CitationYK, Valtis, et al. "CAR HEMATOTOX Independently Predicts Outcomes After CD19 CAR-T Therapy for Acute Lymphoblastic Leukemia." Blood Advances, vol. 10, no. 1, 2026, p. 276, https://doi.org/10.1182/bloodadvances.2025017526.
Warning: These citations may not always be 100% accurate.
